STEMBIOSYS, INC.

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

• CBCatherine BurzikDirector
• BCBecky CapDirector
• PCPaul CastellaDirector
• JCJean CheeverDirector
• XCXiao-Dong ChenDirector
• XCXiao-Dong Chen, M.D.Director · Executive Officer
• ICIan ClementsDirector
• SDSteven DavisDirector
• SDSteven Davis, M.D.Director · Executive Officer
• JFJohn FeikDirector
• EGEdward GriffeyExecutive Officer
• MHMark HorseyDirector · Executive Officer
• RHRobert HutchensDirector · Executive Officer
• RLRobert LangerDirector
• PSPeter SavasDirector · Executive Officer
• CXChen Xiao-DongDirector

• 28 Oct 2025Methods For The Maturation Of Cardiomyocytes On Amniotic Fluid Cell-derived Ecm, Cellular Constructs, And Uses For Cardiotoxicity And Proarrhythmic Screening Of Drug Compoundsgranted
• 08 Apr 2025Amniotic Fluid Cell-derived Extracellular Matrix And Uses Thereofgranted
• 27 Feb 2025Amniotic Fluid Cell-derived Extracellular Matrix And Uses Thereofapplication
• 11 Jan 2022Methods For The Maturation Of Cardiomyocytes On Amniotic Fluid Cell-derived Ecm, Cellular Constructs, And Uses For Cardiotoxicity And Proarrhythmic Screening Of Drug Compoundsgranted
• 23 Nov 2021Amniotic Fluid Cell-derived Extracellular Matrix And Uses Thereofgranted
• 19 Jul 2018Bone Marrow Stromal Cell Derived Extracellular Matrix Protein Extract And Uses Thereofapplication
• 23 Nov 2017Methods For Maintaining And Expanding Mesenchymal Stem Cells On Extracellular Matrix Coated Microcarriersapplication
• 05 Oct 2017Bone Marrow Stromal Cell Derived Extracellular Matrix Protein Extract And Uses Thereofapplication
• —Methods For Maintaining And Expanding Mesenchymal Stem Cells On Extracellular Matrix Coated Microcarriersapplication
• —Methods For The Maturation Of Cardiomyocytes On Amniotic Fluid Cell-derived Ecm, Cellular Constructs, And Uses For Cardiotoxicity And Proarrhythmic Screening Of Drug Compoundsapplication
• —Amniotic Fluid Cell-derived Extracellular Matrix And Uses Thereofapplication
• —Methods For The Maturation Of Cardiomyocytes On Amniotic Fluid Cell-derived Ecm, Cellular Constructs, And Uses For Cardiotoxicity And Proarrhythmic Screening Of Drug Compoundsapplication

• 07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
• 30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
• 30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
• 29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
• 26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
• 26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.